title: Letter by Moris et al Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)".
authors.affiliation: Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH.
authors.forename: Demetrios
authors.initials: D
authors.lastname: Moris
authors.affiliation: Division of Vascular Surgery, Department of Surgery, Laikon General Hospital, Athens, Greece.
authors.forename: Chris
authors.initials: C
authors.lastname: Bakoyiannis
authors.affiliation: Division of Vascular Surgery, University of Pittsburgh Medical Center, PA.
authors.forename: Efthymios
authors.initials: E
authors.lastname: Avgerinos
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives; D001241:Aspirin; D006801:Humans; D002546:Ischemic Attack, Transient; D010975:Platelet Aggregation Inhibitors; D020521:Stroke; D000077486:Ticagrelor; D013988:Ticlopidine
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin